Clinical trial

Mycoplasma Genitalium Antibiotic Susceptibility and Treatment (MEGA)

NCT00358462 · University of Washington, Other · Completed

Key facts

NCT number NCT00358462
Title Mycoplasma Genitalium Antibiotic Susceptibility and Treatment (MEGA)
Official title Mycoplasma Genitalium Antibiotic Susceptibility and Treatment: A Randomized Double-blind Trial of the Efficacy of Azithromycin and Doxycycline for Clinical and Microbiological Cure of M. Genitalium in Men With Nongonococcal Urethritis
Lead sponsor University of Washington, Other
Collaborators National Institute of Allergy and Infectious Diseases (NIAID) NIH
Status Completed
Phase Phase 3
Study type Interventional
Conditions Urethritis
Intervention type Drug
Interventions Azithromycin, Doxycycline
Enrollment 606
Start date Jan 1, 2007
Primary completion Nov 1, 2011
Completion Nov 1, 2011
First posted Jul 31, 2006
Last update posted Aug 15, 2018
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies